Literature DB >> 19751845

Impact of the circadian clock on in vitro genotoxic risk assessment assays.

Eugin Destici1, Małgorzata Oklejewicz, Romana Nijman, Filippo Tamanini, Gijsbertus T J van der Horst.   

Abstract

Our society expects safety assessment for drugs, chemicals, cosmetics, and foods, which to date cannot be achieved without the use of laboratory animals. At the same time, society aims at refining, reducing, and (ultimately) replacing animal testing. As a consequence, much effort is taken to establish alternatives, such as toxicogenomics-based risk assessment assays on cultured cells and tissues. Evidently, the properties of cells in vitro will considerably differ from the in vivo situation. This review will discuss the impact of the circadian clock, an internal time keeping system that drives 24-h rhythms in metabolism, physiology and behavior, on in vitro genotoxic risk assessment. Our recent observation that DNA damaging agents can synchronize the circadian clock of individual cells in culture (and as a consequence the cyclic expression of clock-controlled genes, comprising up to 10% of the transcriptome) implies that the circadian clock should not be neglected when developing cell or tissue-based alternatives for chronic rodent toxicity assays.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19751845     DOI: 10.1016/j.mrgentox.2009.09.001

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  2 in total

1.  Coordination of the transcriptome and metabolome by the circadian clock.

Authors:  Kristin L Eckel-Mahan; Vishal R Patel; Robert P Mohney; Katie S Vignola; Pierre Baldi; Paolo Sassone-Corsi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-19       Impact factor: 11.205

2.  Enhancement of NAD⁺-dependent SIRT1 deacetylase activity by methylselenocysteine resets the circadian clock in carcinogen-treated mammary epithelial cells.

Authors:  Mingzhu Fang; Wei-Ren Guo; Youngil Park; Hwan-Goo Kang; Helmut Zarbl
Journal:  Oncotarget       Date:  2015-12-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.